Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 Cells

Open Access

Peer-reviewed

Research Article

Yani Fang,

Affiliation National Engineering Research Center for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi’an, PR China
⨯
Cheng Zhang,

Affiliation National Engineering Research Center for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi’an, PR China
⨯
Tong Wu,

Affiliation National Engineering Research Center for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi’an, PR China
⨯
Qi Wang,

Affiliation Shaanxi Lifegen Co. Ltd., Xi’an, PR China
⨯
Jinhui Liu,

Affiliation National Engineering Research Center for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi’an, PR China
⨯
Penggao Dai

* E-mail: daipg@nwu.edu.cn

Affiliation National Engineering Research Center for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi’an, PR China
⨯

Reader Comments (0)

Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
MAPK signaling cascades
Is the Subject Area "MAPK signaling cascades" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Transcriptome analysis
Is the Subject Area "Transcriptome analysis" applicable to this article?

Thanks for your feedback.
RNA sequencing
Is the Subject Area "RNA sequencing" applicable to this article?

Thanks for your feedback.